Ambev (NYSE:ABEV) Price Target Raised to $2.50 at Barclays

Ambev (NYSE:ABEV - Get Free Report) had its target price increased by analysts at Barclays from $2.00 to $2.50 in a research report issued on Monday, MarketBeat.com reports. The brokerage currently has an "equal weight" rating on the stock. Barclays's price target indicates a potential downside of 2.15% from the company's current price.

A number of other brokerages also recently weighed in on ABEV. Bank of America downgraded Ambev from a "buy" rating to a "neutral" rating in a report on Friday, January 17th. StockNews.com began coverage on Ambev in a report on Wednesday, April 23rd. They issued a "buy" rating on the stock. UBS Group downgraded Ambev from a "buy" rating to a "neutral" rating in a report on Tuesday, April 22nd. Morgan Stanley downgraded Ambev from an "equal weight" rating to an "underweight" rating in a report on Monday, April 7th. Finally, Citigroup reissued a "neutral" rating on shares of Ambev in a report on Wednesday, January 22nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $2.70.

Ambev Price Performance

NYSE:ABEV traded up $0.02 during trading hours on Monday, reaching $2.56. 18,751,450 shares of the company were exchanged, compared to its average volume of 29,340,415. The company has a market capitalization of $40.26 billion, a P/E ratio of 14.19, a P/E/G ratio of 5.80 and a beta of 0.80. Ambev has a 1-year low of $1.76 and a 1-year high of $2.64. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.20 and a quick ratio of 0.89. The business has a 50 day moving average of $2.38 and a 200 day moving average of $2.14.

Ambev (NYSE:ABEV - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.04 earnings per share for the quarter, meeting analysts' consensus estimates of $0.04. The firm had revenue of $3.92 billion for the quarter, compared to the consensus estimate of $22.40 billion. Ambev had a return on equity of 16.12% and a net margin of 17.02%. Research analysts forecast that Ambev will post 0.18 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. GAMMA Investing LLC raised its position in Ambev by 468.4% during the 1st quarter. GAMMA Investing LLC now owns 10,998 shares of the company's stock worth $26,000 after purchasing an additional 9,063 shares during the last quarter. Integrated Wealth Concepts LLC bought a new position in Ambev during the 1st quarter worth $26,000. Perigon Wealth Management LLC bought a new position in Ambev during the 1st quarter worth $27,000. U.S. Capital Wealth Advisors LLC bought a new position in Ambev during the 1st quarter worth $28,000. Finally, M&T Bank Corp bought a new position in Ambev during the 1st quarter worth $30,000. 8.13% of the stock is owned by institutional investors.

Ambev Company Profile

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.